跳至主要内容
临床试验/NCT05558761
NCT05558761已完成2 期

Clinical Study to Evaluate the Possible Efficacy of Pentoxifylline in Patients With Ulcerative Colitis Treated With Mesalamine

Tanta University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年10月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Improvement in health related quality of life

研究概览

简要总结

The exact underlying mechanisms of ulcerative colitis (UC), an idiopathic, chronic inflammatory disease marked by diffused inflammation of the colon and rectum mucosa, are still unknown. Due to genetic, immune, and environmental factors, UC is highly dependent on cellular immune reactions and exaggerated inflammatory responses. The release of several cytokines, kinins, leukotrienes, platelet-activating factor (PAF), and reactive oxygen species is connected to immunological activity (ROS). Additionally, many of the cytokines will start an acute phase response, making the inflammation worse.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

double-blinded

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years Both males and females will be included Negative pregnancy test and effective contraception

排除标准

  • Breastfeeding Significant liver and kidney function abnormalities Colorectal cancer patients Patients with severe UC Patients taking rectal or systemic steroids Known allergy to the studied medications

研究组 & 干预措施

Pentoxifylline group

Active Comparator

his group will take mesalamine 1 g three times daily plus pentoxifylline 400 mg two times daily

干预措施: Pentoxifylline 400 MG (Drug)

结局指标

主要结局

Improvement in health related quality of life

时间窗: 6 months

Short Form 36 Health Survey (SF-36) will assess the quality of life. The SF-36 is an indicator of overall health status and contains 10 items. The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability

次要结局

  • changes in the level of measured biomarkers.(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mostafa Bahaa

Teaching Assistant

Tanta University

研究点 (1)

Loading locations...

相似试验